June 6, 2024: Innovative test automation platform, Testsigma has raised $8.2 million in a funding round led by MassMutual Ventures, to augment its plans to advance in GenAI practices.
Founded in 2019 by Rukmangada Kandyala, Pratheep Velicherla, Vikram Chaitanya, and Rajesh Reddy, Testsigma leverages Gen AI to offer a low-code test automation platform. This technology enables quality engineering teams to automate testing processes efficiently and at scale without requiring extensive coding knowledge.
At the core of Testsigma’s solution is its Natural Language Programming (NLP) engine. This engine allows users to create, manage, and execute comprehensive automated tests for web applications, mobile apps, and Application Programming Interfaces (APIs).
MassMutual Ventures Leads the Funding Round for Testsigma
Building on previous success, including a $4.6 million funding round in 2022, Testsigma is continuing to innovate. The company has introduced new generative AI capabilities designed to enhance the productivity and effectiveness of quality assurance (QA) teams. These features enable QA professionals to generate test scenarios and cases from various inputs, such as URLs, product designs, screenshots, and Jira stories.
CEO Rukmangada Kandyala expressed enthusiasm about the advancements, stating, “With the new GenAI capabilities and our new product for the Salesforce ecosystem, we get one step closer to our vision of building the operating system for quality engineering teams. We have been investing heavily in GenAI, and our customers are rapidly adopting generative AI practices.”
Testsigma’s solutions are trusted by leading companies including Cisco, Oscar, Bosch, and Samsung, underscoring its impact on the industry. The fresh capital will likely accelerate the development and adoption of the test automation platform AI-driven test automation tools, further solidifying its position in the market.
Existing investors Accel, Strive, and BoldCap also participated in the funding round
